Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Health and Social Care Secretary Takes Reform Agenda on the Road
Health and Social Care Secretary Sajid Javid will be on the ‘road to recovery’ this […]
NHS Publishes Electives Recovery Plan To Boost Capacity And Give Power To Patients
The NHS and government have today set out a blueprint to address backlogs built up during the Covid […]
England to Return to Plan A Following the Success of the Booster Programme
The government has today announced that England will fully return to Plan A on Thursday […]
NHS Strikes New Covid Surge Deal With Independent Sector
Local hospitals will be able to quickly activate surge capacity in the independent sector as […]
Testing Measures to Ensure Young People Return to Classrooms
All secondary schools have been asked to provide one on-site test for pupils ahead of […]
UK's Most Vulnerable People to Receive Life-saving COVID-19 Treatments in the Community
Thousands of the UK’s most vulnerable people will be among the first in the world to […]
Government to Invest £375 Million in Neurodegenerative Disease Research
People living with neurodegenerative diseases could live longer, healthier lives due to innovative new research, […]
Booster Bookings Boom As One Million Book Life-Saving Jab in Three Days
More than one million booster jabs have been booked in the last three days as […]
First Oral Antiviral for COVID-19, Lagevrio (molnupiravir), Approved by MHRA
The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and […]
NHS Offers Home Blood Pressure Checks to Save Thousands of Lives
Hundreds of thousands of people will be able to test their blood pressure at home, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more